Search Results 3351-3360 of 17079 for pharmacogenetics
Mayo Clinic Q&A podcast: COVID-19 trials pause over safety concerns featured image · Aging · Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ ...
Changes in how brain cells generate energy may drive the development of Alzheimer's disease and influence how patients respond to therapy, according to a new[..
About this study. THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a ...
Marla Broadfoot, Ph.D. March 4, 2026. Mayo Clinic researchers identify key DNA changes in the brains of people with Alzheimer's disease featured.
Preparing the workforce of the future: students work side-by-side with Mayo researchers and physicians. Mayo Clinic Staff. November 4, 2019.
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
JACKSONVILLE, Fla. — Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year[...] ...
The purpose of this study to evaluate the feasibility and safety of placing the MLG-Complete allograft during nerve-sparing robotic prostatectomy. Secondary ...
Mayo Clinic deploys NVIDIA Blackwell infrastructure to drive generative AI solutions in medicine featured image · Mayo Clinic researchers link CAR-T cell aging ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!